Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease
about
Recent Treatments of Interstitial Lung Disease with Systemic SclerosisDabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.Imaging lung disease in systemic sclerosis.Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease.Scleroderma lung diseaseSystemic Sclerosis-Associated Interstitial Lung Disease: Lessons from Clinical Trials, Outcome Measures, and Future Study Design.Acute respiratory failure in critically ill patients with interstitial lung disease.Lung involvement in systemic sclerosis.Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis.Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: analysis of the Scleroderma Lung Study Placebo Group.The current state of biomarkers in systemic sclerosisCorrelation of cough with disease activity and treatment with cyclophosphamide in scleroderma interstitial lung disease: findings from the Scleroderma Lung Study.Histopathology and bronchoalveolar lavageBronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study.Pulmonary complications: one of the most challenging complications of systemic sclerosis.Evidence-based management of rapidly progressing systemic sclerosis.Bronchoalveolar lavage and other methods to define the human respiratory tract milieu in health and disease.Molecular biomarkers in interstitial lung diseases.Risk factors for severity and manifestations in systemic sclerosis and prediction of disease course.Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies.Cyclophosphamide for connective tissue disease-associated interstitial lung disease.Determinants of mortality in systemic sclerosis: a focused review.Update in diffuse parenchymal lung disease 2008.Bronchoalveolar lavage in systemic sclerosis with lung involvement: role and correlations with functional, radiological and scintigraphic parameters.Scleroderma lung disease: "if you don't know where you are going, any road will take you there".Scleroderma Lung DiseaseBronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease
P2860
Q26773161-2216029B-80DC-4A7B-8314-15064FF35529Q33722844-A9F2F8C2-8BB3-45A4-917C-DC51F999038AQ33754571-ED5C58B3-CEC4-4AD4-93EA-CD6E357BE684Q33891119-9C61F456-CE07-4CF4-8E3B-3CE36C849F8DQ33919119-A9ACF3D8-446D-4281-830A-26C0E5852662Q34027197-D64F34FD-2441-4801-ADBD-2C837DF09151Q34035577-78BC01D4-D3E0-43D8-AB3D-06E2D0B70DC8Q34732817-873DABC8-78F7-4D00-929B-BE5F79C0FC46Q35064030-704D41D3-F689-4E6F-B4F5-0C7590A3DD1AQ35242200-E1D51C7E-7329-4C82-8288-4A0FAE5A2A6CQ35896754-CB41687F-6025-4199-A515-08518A8BA797Q36212638-EA763D4A-719B-4694-B481-F2B3355AD013Q37265872-6150CD44-7EC3-43AD-A671-7DDD19B0F42AQ37350899-20F0CB2D-4BD0-4634-84FE-2CDEF052F2B1Q37412005-4F8B780A-752E-4FC0-9624-A72E9F6494B5Q37504310-6F9E0185-8DF7-4FDF-8DA4-B9F53A27565FQ37763779-85AC42D2-8844-4FEE-9C69-6CBB72BCED52Q37847083-79D8BBDF-DD12-4EDC-B4F5-9D360CC14B12Q38220769-9F0E3CBD-9E08-4C5E-BD92-06F0AEDECFB5Q38630663-32281B65-01D2-477D-A72E-0CFB06EE0A0BQ38936954-459687BC-3E37-4D05-B7B9-6B01979252B4Q47216089-F1B6F3AC-AEEC-48A5-8894-27F68D54E2E3Q47633128-9B66059C-4DEB-4C40-92D7-6393BEDC3ADAQ51782313-B8630C4A-2DED-4035-B088-EDCA8F9E7A9FQ53302300-7A6E9FF0-CC47-4A66-A5AA-B79761484668Q53416075-CC5EB889-B2B6-4D4A-9707-4F0B9673BFACQ56977976-7886AA17-DDF6-4F87-B344-39E8EC8D0AE6Q57753247-9F03E8D5-B96D-46E8-A460-44B76FFAC56F
P2860
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Bronchoalveolar lavage and res ...... erma interstitial lung disease
@ast
Bronchoalveolar lavage and res ...... erma interstitial lung disease
@en
type
label
Bronchoalveolar lavage and res ...... erma interstitial lung disease
@ast
Bronchoalveolar lavage and res ...... erma interstitial lung disease
@en
prefLabel
Bronchoalveolar lavage and res ...... erma interstitial lung disease
@ast
Bronchoalveolar lavage and res ...... erma interstitial lung disease
@en
P2093
P2860
P1476
Bronchoalveolar lavage and res ...... erma interstitial lung disease
@en
P2093
Arthur Theodore
Charlie Strange
Daniel E Furst
Donald P Tashkin
Edwin A Smith
Joanie Chung
Jonathan Goldin
Marcy B Bolster
Michael D Roth
Philip Clements
P2860
P356
10.1164/RCCM.200705-655OC
P407
P577
2007-09-27T00:00:00Z